Skip to main content
Erschienen in: Clinical Neuroradiology 1/2013

01.03.2013 | Original Article

Involvement of Globus Pallidus and Midbrain Nuclei in Pantothenate Kinase-Associated Neurodegeneration

Measurement of T2 and T2* Time

verfasst von: R. Fermin-Delgado, MD, P. Roa-Sanchez, MD, H. Speckter, BA, E. Perez-Then, MD, D. Rivera-Mejia, MD, B. Foerster, BA, P. Stoeter, MD

Erschienen in: Clinical Neuroradiology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To quantify involvement of globus pallidus and two midbrain nuclei (substantia nigra and red nucleus) in Pantothenate Kinase-Associated Neurodegeneration (PKAN).

Material and Methods

We performed T2 and T2* weighted imaging with calculation of the corresponding relaxation times on a subset of 5 patients from a larger group of 20 patients with PKAN from the southwest part of the Dominican Republic. Examinations were carried out on a 3T scanner and included a multi-echo spin-echo as well as a multi-echo gradient echo sequence. Results were compared to a control group of 19 volunteers.

Results

T2 and T2* weighted sequences showed abnormal signal reduction in the globus pallidus of all patients. On T2* weighted imaging, abnormal signal in the substantia nigra could reliably be detected in 75% of cases, but differentiation from normal was less reliable in T2 weighted scans. Correspondingly, relaxation times differed from normal with very high significance (p < 0.0001) in the globus pallidus, but with with less significance in the substantia nigra (p ≤ 0.03). The red nucleus was not affected.

Conclusions

Signal reduction in the globus pallidus, which probably is due to abnormal accumulation of iron, is severe in PKAN and can be differentiated from normal with high reliability. The substantia nigra is affected to a lesser degree, and the red nucleus is not involved. The reason for this selective susceptibility of normally iron-rich brain structures for pathological accumulation of iron remains speculative. Our quantitative results might be helpful to assess the value of an iron chelation approach to therapy.
Literatur
1.
Zurück zum Zitat Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003;348:33–40.PubMedCrossRef Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003;348:33–40.PubMedCrossRef
2.
Zurück zum Zitat Pellecchia MT, Valente EM, Cif L, Salvi S, Albanese A, Scarano V, et al. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology. 2005;64:1810–12.PubMedCrossRef Pellecchia MT, Valente EM, Cif L, Salvi S, Albanese A, Scarano V, et al. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology. 2005;64:1810–12.PubMedCrossRef
3.
Zurück zum Zitat Delgado RF, Sanchez PR, Speckter H, Then EP, Jimenez R, Oviedo J, Dellani PR, Foerster B, Stoeter P. Missense PANK2 mutation without “eye of the tiger sign”—MR findings in a large group of patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN). J Magn Reson Imaging. 2011 [Epub ahead of print]. Delgado RF, Sanchez PR, Speckter H, Then EP, Jimenez R, Oviedo J, Dellani PR, Foerster B, Stoeter P. Missense PANK2 mutation without “eye of the tiger sign”—MR findings in a large group of patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN). J Magn Reson Imaging. 2011 [Epub ahead of print].
4.
Zurück zum Zitat Senegas J, Bos C, Dahnke H. Determining precision of relaxation time measurements: application to T2 mapping. ISMRM 2008; 16th Scientific Meeting, Toronto/Can. Proceedings 2008, p. 1421. Senegas J, Bos C, Dahnke H. Determining precision of relaxation time measurements: application to T2 mapping. ISMRM 2008; 16th Scientific Meeting, Toronto/Can. Proceedings 2008, p. 1421.
5.
Zurück zum Zitat Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage. 2009;47:493–500.PubMedCrossRef Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage. 2009;47:493–500.PubMedCrossRef
6.
Zurück zum Zitat Peran P, Cherubini A, Luccichenti G, Hagberg G, Démonet JF, Rascol O, et al. Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp. 2009;30:2667–75.PubMedCrossRef Peran P, Cherubini A, Luccichenti G, Hagberg G, Démonet JF, Rascol O, et al. Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp. 2009;30:2667–75.PubMedCrossRef
7.
Zurück zum Zitat Langkammer C, Enzinger C, Quasthoff S, Grafenauer P, Soellinger M, Fazekas F, et al. Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis. J Magn Reson Imaging. 2010;31:1339–45.PubMedCrossRef Langkammer C, Enzinger C, Quasthoff S, Grafenauer P, Soellinger M, Fazekas F, et al. Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis. J Magn Reson Imaging. 2010;31:1339–45.PubMedCrossRef
8.
Zurück zum Zitat Szumowski J, Bas E, Gaarder K, Schwarz E, Erdogmus D, Hayflick S. Measurement of brain iron distribution in Hallervorden-Spatz syndrome. J Magn Reson Imaging. 2010;31:482–9. Szumowski J, Bas E, Gaarder K, Schwarz E, Erdogmus D, Hayflick S. Measurement of brain iron distribution in Hallervorden-Spatz syndrome. J Magn Reson Imaging. 2010;31:482–9.
9.
Zurück zum Zitat Helms G, Draganski B, Frackowiak R, Ashburner J, Weiskopf N. Improved segmentation of deep brain grey matter structures using magnetization transfer parameter maps. Neuroimage. 2009;47:194–8.PubMedCrossRef Helms G, Draganski B, Frackowiak R, Ashburner J, Weiskopf N. Improved segmentation of deep brain grey matter structures using magnetization transfer parameter maps. Neuroimage. 2009;47:194–8.PubMedCrossRef
10.
Zurück zum Zitat Vyzmal J, Hajek M, Patronas N, Gledd JN, Bulte JW, Baumgarner C, et al. The quantitative relation between T1-weighted and T2-weighted MRI of normal grey matter and iron concentration. J Magn Reson Imaging. 1995;5:554–60.CrossRef Vyzmal J, Hajek M, Patronas N, Gledd JN, Bulte JW, Baumgarner C, et al. The quantitative relation between T1-weighted and T2-weighted MRI of normal grey matter and iron concentration. J Magn Reson Imaging. 1995;5:554–60.CrossRef
11.
Zurück zum Zitat Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23:1–25.PubMedCrossRef Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23:1–25.PubMedCrossRef
12.
Zurück zum Zitat Aquino D, Bizzi A, Grisoli M, Garavaglia B, Bruzzone MG, Nardocci N, et al. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology. 2009;252:165–72.PubMedCrossRef Aquino D, Bizzi A, Grisoli M, Garavaglia B, Bruzzone MG, Nardocci N, et al. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology. 2009;252:165–72.PubMedCrossRef
13.
Zurück zum Zitat Sullivan EV, Adalsteinsson E, Rohlfing T, Pfefferbaum A. Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: exploratory findings. Brain Imaging Behav. 2009;3:167–75.PubMedCrossRef Sullivan EV, Adalsteinsson E, Rohlfing T, Pfefferbaum A. Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: exploratory findings. Brain Imaging Behav. 2009;3:167–75.PubMedCrossRef
14.
Zurück zum Zitat Bartzokis G, Lu PH, Tishler TA, Peters DG, Kosenko A, Barrall KA, et al. Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis. 2010;20:333–41.PubMed Bartzokis G, Lu PH, Tishler TA, Peters DG, Kosenko A, Barrall KA, et al. Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis. 2010;20:333–41.PubMed
15.
Zurück zum Zitat Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol. 2007;28:1639–44.PubMedCrossRef Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol. 2007;28:1639–44.PubMedCrossRef
16.
Zurück zum Zitat Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007;4:371–86.PubMedCrossRef Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007;4:371–86.PubMedCrossRef
17.
Zurück zum Zitat Hayflick SJ, Hartman M, Coryell J, Gitschier J, Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol. 2006;27:1230–3.PubMed Hayflick SJ, Hartman M, Coryell J, Gitschier J, Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol. 2006;27:1230–3.PubMed
18.
Zurück zum Zitat Gupta R, Kumar A, Sharma MC, Sarkar C, Goyal V, Bihari M. Autopsy always teach and tell: neurodegeneration with brain iron accumulation: a case report. Indian J Pathol Microbiol. 2007;50:792–4.PubMed Gupta R, Kumar A, Sharma MC, Sarkar C, Goyal V, Bihari M. Autopsy always teach and tell: neurodegeneration with brain iron accumulation: a case report. Indian J Pathol Microbiol. 2007;50:792–4.PubMed
19.
Zurück zum Zitat Hájek M, Adamovicová M, Herynek V, Skoch A, Jírů F, Krepelová A, et al. MR relaxometry and 1 H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Eur Radiol. 2005;15:1060–8.PubMedCrossRef Hájek M, Adamovicová M, Herynek V, Skoch A, Jírů F, Krepelová A, et al. MR relaxometry and 1 H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Eur Radiol. 2005;15:1060–8.PubMedCrossRef
20.
Zurück zum Zitat Hayflick SJ. Unravelling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr Opin Pediatr. 2003;15:572–7.PubMedCrossRef Hayflick SJ. Unravelling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr Opin Pediatr. 2003;15:572–7.PubMedCrossRef
21.
Zurück zum Zitat Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, et al. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol. 1985;18:492–9.CrossRef Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, et al. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol. 1985;18:492–9.CrossRef
22.
Zurück zum Zitat Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Ges Neurol Psychiatr. 1922;79:254–302.CrossRef Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Ges Neurol Psychiatr. 1922;79:254–302.CrossRef
23.
Zurück zum Zitat Desai VS, Bindu PS, Ravishankar PN, Pal PK. Relaxation and susceptibility MRI characteristics in Hallervorden-Spatz syndrome. J Magn Reson Imaging. 2007;25:715–20.CrossRef Desai VS, Bindu PS, Ravishankar PN, Pal PK. Relaxation and susceptibility MRI characteristics in Hallervorden-Spatz syndrome. J Magn Reson Imaging. 2007;25:715–20.CrossRef
24.
Zurück zum Zitat McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008;70:1614–9.PubMedCrossRef McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008;70:1614–9.PubMedCrossRef
25.
Zurück zum Zitat Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. Am J Roentgenol. 1986;147:103–10.CrossRef Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. Am J Roentgenol. 1986;147:103–10.CrossRef
26.
Zurück zum Zitat Clement F, Devos D, Moreau C, Coubes P, Destee A, Defebvre L. Neurodegeneration with brain iron accumulation: clinical, radiographic, and genetic heterogeneity and corresponding therapeutic options. Acta Neurol Belg. 2007;107:26–31.PubMed Clement F, Devos D, Moreau C, Coubes P, Destee A, Defebvre L. Neurodegeneration with brain iron accumulation: clinical, radiographic, and genetic heterogeneity and corresponding therapeutic options. Acta Neurol Belg. 2007;107:26–31.PubMed
27.
Zurück zum Zitat Forni GL, Balocco M, Cremonesi L, Abbruzzese G, Parodi RC, Marchese R. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation. Mov Disord. 2008;23:904–7.PubMedCrossRef Forni GL, Balocco M, Cremonesi L, Abbruzzese G, Parodi RC, Marchese R. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation. Mov Disord. 2008;23:904–7.PubMedCrossRef
28.
Zurück zum Zitat Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A, et al. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord. 2011;26:1756–9.PubMedCrossRef Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A, et al. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord. 2011;26:1756–9.PubMedCrossRef
Metadaten
Titel
Involvement of Globus Pallidus and Midbrain Nuclei in Pantothenate Kinase-Associated Neurodegeneration
Measurement of T2 and T2* Time
verfasst von
R. Fermin-Delgado, MD
P. Roa-Sanchez, MD
H. Speckter, BA
E. Perez-Then, MD
D. Rivera-Mejia, MD
B. Foerster, BA
P. Stoeter, MD
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Clinical Neuroradiology / Ausgabe 1/2013
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-011-0127-9

Weitere Artikel der Ausgabe 1/2013

Clinical Neuroradiology 1/2013 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.